Literature DB >> 35028857

High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma.

Ming Yan1, Xiaojun Yin2, Luan Zhang3, Yuanbo Cui4, Xiwen Ma5.   

Abstract

BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most prevalent human cancers worldwide. The homeobox-B (HOXB) gene cluster has been reported to contribute to cancer development. Nevertheless, the expression status, clinical significance and biological role of HOXB genes in LUAD remain largely unclear. METHODS AND
RESULTS: This study comprehensively investigated the transcriptional levels and prognostic values of the HOXB genes in LUAD based on The Cancer Genome Atlas (TCGA) database. Flow cytometry, CCK-8, and Transwell assays were used for detecting apoptosis, proliferation, and migration, respectively. We discovered that eight members of the HOXB cluster genes (HOXB2, HOXB3, HOXB4, HOXB6, HOXB7, HOXB8, HOXB9, and HOXB13) were dysregulated in LUAD tumor tissues. Increased expression of HOXB3, HOXB6, HOXB7, HOXB8, or HOXB9 was independently associated with unsatisfactory overall survival (OS) in LUAD patients. In addition, a high level of HOXB3 also predicted poor patient relapse-free survival (RFS), suggesting that HOXB3 may play a vital role in the progression of LUAD compared to other members of the HOXB cluster. Additionally, further analysis by TIMER and TISIDB algorithms revealed that HOXB3 was positively correlated with a panel of immune checkpoint molecules (ICMs), tumor-infiltrating lymphocytes (TILs), and tumor immune regulators (TIRs). Gene enrichment analysis based on KEGG showed that HOXB3 was closely associated with multiple tumor-related biological processes and signaling pathways. Functionally, the in vitro experiments revealed that depletion of HOXB3 significantly alleviated the resistance of LUAD cells to apoptosis, and suppressed cell proliferation and migration.
CONCLUSION: Our study suggests that HOXB3 may play an oncogenic role in LUAD and correlate with tumor immunity.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  HOXB3; Homeobox-B cluster genes; Lung adenocarcinoma; TCGA; Tumor immunity

Mesh:

Substances:

Year:  2022        PMID: 35028857     DOI: 10.1007/s11033-021-07064-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  5 in total

1.  HOXB5 promotes retinoblastoma cell migration and invasion via ERK1/2 pathway-mediated MMPs production.

Authors:  Haiming Xu; Hailan Zhao; Jie Yu
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

2.  Immunocytochemical detection of homeobox B3, B4, and C6 gene product expression in lung carcinomas.

Authors:  B Bodey; B Bodey; A M Gröger; S E Siegel; H E Kaiser
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

3.  Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer.

Authors:  Xuetian Gao; Ling Peng; Li Zhang; Kai Huang; Cuihua Yi; Bei Li; Xue Meng; Jisheng Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-11-08       Impact factor: 4.322

4.  Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab.

Authors:  Hyungwoo Cho; Min-Hee Ryu; Hyung Eun Lee; Hyung-Don Kim; Yoon-Koo Kang
Journal:  Cancer Immunol Immunother       Date:  2021-08-22       Impact factor: 6.968

Review 5.  Role of HOX Genes in Stem Cell Differentiation and Cancer.

Authors:  Seema Bhatlekar; Jeremy Z Fields; Bruce M Boman
Journal:  Stem Cells Int       Date:  2018-07-22       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.